Related Experiment Video
Updated: Jun 22, 2025

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
9.9K
[Chinese expert consensus on the diagnosis and management of elderly patients with diffuse large B-cell lymphoma
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|July 1, 2024
Abstract:
The general population in China is aging, and thus the number of older patients with diffuse large B-cell lymphoma (DLBCL) will continue to increase. Individualized treatment is required to maximize therapeutic potential while minimizing the risk of toxicity. To improve the diagnosis and treatment of DLBCL in older people in China, the Lymphocyte Disease Group of the Hematology Division of the Chinese Medical Association and Lymphoma Expert Commitee of Chinese Society of Clinical Oncology (CSCO) have organized relevant experts to formulate this consensus.

